Board of Lincoln Pharmaceuticals recommends final dividend

Of Rs 1.2 per share

Lincoln Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 30 May 2017, inter alia, have recommended the final dividend of Rs 1.2 per equity Share (i.e. 12%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News